EUVIMEDEUVIMED entdecken
Fallbericht

Renal Candidal Bezoar in an Sodium-Glucose Cotransporter-2 Inhibitor User With an Indwelling Ureteral Stent: A Case Report and Review of the Literature

Wei-An Chen, Hao Xiang Chen

Urologia Internationalis · 09.10.2026 · 1-1

DOI: 10.1159/uin/aewag035 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Urologia Internationalis, online erschienen am 09.10.2026. Verfasst von Wei-An Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, China Medical University Hospital, China Medical University, Taichung, Taiwan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Renal candidal bezoar is a rare cause of obstructive pyonephrosis and usually occurs in patients with diabetes mellitus, immunosuppression, urinary obstruction, or indwelling urinary devices. Case Presentation: We report an 88-year-old man with type 2 diabetes treated with dapagliflozin, stage 3 chronic kidney disease, and a history of ureteral stricture managed with ureteral stenting who developed recurrent candidal pyonephrosis and extensive fungal bezoar involving the ureter and renal pelvis. Initial treatment at a referring hospital included percutaneous nephrostomy drainage, fluconazole therapy, ureteroscopic ureterotomy, and ureteral stent placement. The patient re-presented with fever and pyonephrosis and was presented to our emergency department. Dapagliflozin was discontinued, the ureteral stent was exchanged, and fluconazole with a short course of flucytosine was administered pending susceptibility testing. Cultures confirmed fluconazole-susceptible Candida albicans. Staged ureteroscopic debridement using forceps and aspiration achieved complete clearance, followed by renal functional recovery and clinical resolution.

Conclusion

This case highlights the need to reassess medication-associated glycosuria, indwelling stent exposure, and mechanical source control in refractory upper tract candidal bezoar. A review of reported cases suggests that drainage and antifungal therapy are essential, but active endoscopic, percutaneous, or surgical removal is frequently required when organized fungal material persists.

Schlagwörter

Stichwörter der Autor:innen

Candida albicansCase reportFungal bezoarSodium-glucose cotransporter-2 inhibitorUreteral stentUreteroscopy

Autor:innen und Institutionen

  • Department of Urology, China Medical University Hospital, China Medical University, Taichung, Taiwan.
  • Department of Urology, China Medical University Hospital, China Medical University, Taichung, Taiwan, 029933@tool.caaumed.org.tw.
  • Division of Urology, Department of Surgery, China Medical University Beigang Hospital, Beigang, Taiwan, 029933@tool.caaumed.org.tw.

Zitieren

APA

Chen, W. A., & Chen, H. X. (2026). Renal Candidal Bezoar in an Sodium-Glucose Cotransporter-2 Inhibitor User With an Indwelling Ureteral Stent: A Case Report and Review of the Literature. Urologia Internationalis, 1-1. https://doi.org/10.1159/uin/aewag035

Vancouver

Chen WA, Chen HX. Renal Candidal Bezoar in an Sodium-Glucose Cotransporter-2 Inhibitor User With an Indwelling Ureteral Stent: A Case Report and Review of the Literature. Urologia Internationalis. 2026:1-1. doi:10.1159/uin/aewag035

BibTeX
@article{Chen2026,
  author = {Chen, Wei-An and Chen, Hao Xiang},
  title = {Renal Candidal Bezoar in an Sodium-Glucose Cotransporter-2 Inhibitor User With an Indwelling Ureteral Stent: A Case Report and Review of the Literature},
  journal = {Urologia Internationalis},
  year = {2026},
  pages = {1--1},
  doi = {10.1159/uin/aewag035}
}
Kostenlos starten →